5 reports of this reaction
3.4% of all ALUMINUM CHLOROHYDRATE reports
#3 most reported adverse reaction
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE is the #3 most commonly reported adverse reaction for ALUMINUM CHLOROHYDRATE, manufactured by The Procter & Gamble Manufacturing Company. There are 5 FDA adverse event reports linking ALUMINUM CHLOROHYDRATE to PRODUCT ADMINISTERED AT INAPPROPRIATE SITE. This represents approximately 3.4% of all 148 adverse event reports for this drug.
Patients taking ALUMINUM CHLOROHYDRATE who experience product administered at inappropriate site should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE is moderately reported among ALUMINUM CHLOROHYDRATE users, representing a notable but not dominant share of adverse events.
In addition to product administered at inappropriate site, the following adverse reactions have been reported for ALUMINUM CHLOROHYDRATE:
The following drugs have also been linked to product administered at inappropriate site in FDA adverse event reports:
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE has been reported as an adverse event in 5 FDA reports for ALUMINUM CHLOROHYDRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE accounts for approximately 3.4% of all adverse event reports for ALUMINUM CHLOROHYDRATE, making it one of the most commonly reported side effect.
If you experience product administered at inappropriate site while taking ALUMINUM CHLOROHYDRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.